Ms. Carver leads the full commercial vertical at Prenosis, spanning product management, marketing, sales, public relations, operations and customer experience. The company is developing the only FDA-authorized AI diagnostic for sepsis, called Sepsis ImmunoScore. A registered nurse who spent nearly 14 years at Raleigh, N.C.-based WakeMed Health & Hospitals, rising from staff nurse to director of infection prevention, Ms. Carver achieved an 87% reduction in central line bloodstream infections, eliminated ventilator-associated pneumonia in the medical ICU and sustained hand hygiene compliance at 90%, with research published in the American Journal of Infection Control. At Premier, she led product launch, commercialization and partnerships for safety surveillance and quality solutions, exceeding sales goals by 25% and growing revenue by 200% over nearly 11 years. Prenosis was named a TIME “Best Invention” in 2024 and a Fast Company “World Changing Ideas” honoree in 2025. Ms. Carver also serves as a nursing mentor at the University of North Carolina at Chapel Hill and as vice president of the CNO affinity group lead at Premier.
